Athena Wealth Management
ABBV icon

Athena Wealth Management’s AbbVie ABBV Stock Holding History

Athena Wealth Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$1.09M Buy
4,167
+406
+11% +$104K 0.78% 28
2026
Q2 		$946K Buy
+3,761
New +$809K 0.7% 38

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $468B AUM 17.69% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $191B AUM 30.51% 1-Year Est. Return

Athena Wealth Management's ABBV Position: Q3 2026 in Review

Athena Wealth Management increased its AbbVie (ABBV) stake by 11% in Q3 2026, buying an estimated $104K and bringing the position to 4,167 shares worth $1.09M. The position accounts for 0.78% of the portfolio, ranked #28.

Athena Wealth Management first reported a position in ABBV in Q2 2026 and has held it in 2 quarters since. 2,709 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Athena Wealth Management held 4,167 shares of AbbVie worth $1.09M as of Q3 2026.
  • Athena Wealth Management bought 406 AbbVie shares in Q3 2026, an estimated $104K.
  • AbbVie made up 0.78% of Athena Wealth Management's portfolio in Q3 2026, its #28 holding.
  • Athena Wealth Management first reported a position in AbbVie in Q2 2026 and has held it in 2 quarters since.
  • 2,709 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Athena Wealth Management's 13F filing for Q3 2026, filed 9 Oct 2026.